REFERENCES
1. Schache AG, Powell NG, Cuschieri KS, et al. HPV-related oropharynx cancer in the United Kingdom: an evolution in the understanding of disease etiology. Cancer Res. 2016;76(22):6598-6606. https://doi.org/10.1158/0008-5472.CAN-16-0633
2. Shaha AR. Mandibulotomy and mandibulectomy in difficult tumors of the base of the tongue and oropharynx. Semin Surg Oncol.1991;7(1):25-30. doi: 10.1002/ssu.2980070107.
3. O’Hara J, MacKenzie K. Surgical versus non-surgical management of early stage oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2011;268(3):437-442. https://doi.org/10.1007/s00405-010-1362-4
4. Pignon J-P, Le Maitre A, Maillard E, Bourhis J, Group M-NC. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol . 2009;92(1):4-14. https://doi.org/10.1016/j.radonc.2009.04.014
5. Abendstein H, Nordgren M, Boysen M, et al. Quality of life and head and neck cancer: a 5 year prospective study. Laryngoscope.2005;115(12):2183-2192. https://doi.org/10.1097/01.MLG.0000181507.69620.14
6. Peponi E, Glanzmann C, Willi B, Huber G, Studer G. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol . 2011;6(1):1. https://doi.org/10.1186/1748-717X-6-1
7. Wilson JA, Carding PN, Patterson JM. Dysphagia after nonsurgical head and neck cancer treatment: patients’ perspectives. Otolaryngol Head Neck Surg. 2011;145(5):767-771. https://doi.org/10.1177/0194599811414506
8. Paleri V, Patterson J. Use of gastrostomy in head and neck cancer: a systematic review to identify areas for future research. Clin Otolaryngol. 2010;35(3):177-189. https://doi.org/10.1111/j.1749-4486.2010.02128.x
9. Weinstein GS, O’Malley BW, Cohen MA, Quon H. Transoral robotic surgery for advanced oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2010;136(11):1079-1085. https://doi.org/10.1001/archoto.2010.191
10. Iseli TA, Kulbersh BD, Iseli CE, Carroll WR, Rosenthal EL, Magnuson JS. Functional outcomes after transoral robotic surgery for head and neck cancer. Otolaryngol Head Neck Surg. 2009;141(2):166-171. https://doi.org/10.1016/j.otohns.2009.05.014
11. Dziegielewski PT, Teknos TN, Durmus K, et al. Transoral Robotic Surgery for Oropharyngeal Cancer: Long-term Quality of Life and Functional Outcomes. JAMA Otolaryngol Head Neck Surg.2013;139(11):1099-1108. https://doi.org/10.1001/jamaoto.2013.2747
12. Ling DC, Chapman BV, Kim J, et al. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Oral Oncol. 2016;61:41-46. https://doi.org/10.1016/j.oraloncology.2016.08.004
13. Achim V, Bolognone RK, Palmer AD, et al. Long-term functional and quality-of-life outcomes after transoral robotic surgery in patients with oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg.2018;144(1):18-27. https://doi.org/10.1001/jamaoto.2017.1790
14. Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: a systematic review.Eur Arch Otorhinolaryngol . 2015;272(2):463-471. https://doi.org/10.1007/s00405-014-2985-7
15. Moore EJ, Olsen KD, Kasperbauer JL. Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes. Laryngoscope009;119(11):2156-2164. https://doi.org/10.1002/lary.20647
16. Moore EJ, Olsen SM, Laborde RR, et al. Long-term Functional and Oncologic Results of Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma. Mayo Clin Proc. 2012;87(3):219-225. https://doi.org/10.1016/j.mayocp.2011.10.007
17. Sharma A, Patel S, Baik FM, et al. Survival and Gastrostomy Prevalence in Patients With Oropharyngeal Cancer Treated With Transoral Robotic Surgery vs Chemoradiotherapy. JAMA Otolaryngol Head Neck Surg. 2016;142(7):691-697. https://doi.org/10.1001/jamaoto.2016.1106
18. Sinclair CF, McColloch NL, Carroll WR, Rosenthal EL, Desmond RA, Magnuson JS. Patient-Perceived and Objective Functional Outcomes Following Transoral Robotic Surgery for Early Oropharyngeal Carcinoma.Arch Otolaryngol Head Neck Surg. 2011;137(11):1112-1116. https://doi.org/10.1001/archoto.2011.172
19. Shin MJ KJ, Lee SB, Lee SY. Speech mechanism screening test. Seoul, South Korea: Hakjisa Publisher; 2010.
20. Bressmann T, Sader R, Whitehill TL, Samman N. Consonant intelligibility and tongue motility in patients with partial glossectomy. J Oral Maxillofac Surg. 2004;62(3):298-303. https://doi.org/10.1016/j.joms.2003.04.017
21. Fynes MM, Smith C, Brodsky MB. The Modified Barium Swallow Study: When, How, and Why? Appl Radiol. 2019;48:3-8.
22. Brierley JD, Gospodarowicz MK, Wittekind C (Eds.) TNM classification of malignant tumours. Oxford, UK; Wiley-Blackwell; 2017.
23. De Almeida JR, Byrd JK, Wu R, et al. A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: a systematic review. Laryngoscope. 2014;124(9):2096-2102. https://doi.org/10.1002/lary.24712
24. Su HK, Ozbek U, Likhterov I, et al. Safety of transoral surgery for oropharyngeal malignancies: an analysis of the ACS NSQIP.Laryngoscope. 2016;126(11):2484-2491. https://doi.org/10.1002/lary.26024